RESULTS: DM tolerated 3 hours of constant CO2 anesthesia in combination with X-ray radiation exposure throughout the uCT acquisition, during which the optimal scanning protocol achieved DM survival and minimal image-noise. With this method, successful 3D reconstruction and visualization of DM adults were reproduced at 5.72 um isotropic voxel spacing, with stones clearly present (Fig.1) . Analysis of the impact of BS168 on stone formation is ongoing.
INTRODUCTION AND OBJECTIVES: Absorptive hypercalciuria, or excessive gut absorption of dietary calcium, is the most commonly identified metabolic cause of calcium-based renal stones. Since intestinal commensal bacteria are known to play an integral role in nutrient metabolism, we hypothesized that gut microbiota may affect calcium absorption and tested this using an antibiotic rodent model. METHODS: Young, pathogen-free Sprague-Dawley rats were evenly distributed into untreated controls (UTX; n[12), chloramphenicol-treated (CTX; n[12) and neomycin-treated (NEO; n[12) groups. Urine and feces were collected in metabolic cages before (baseline) and after (1 week, 4 weeks) a 7 day course of 0.07% oral antibiotic treatment in sterile water. Rats received identical amounts of food quantity during collection periods and ad-libitum amounts during the remainder of the protocol. Serum calcium, phosphate, and albumin were measured at 4 weeks on an automated chemistry analyzer. Rat intact PTH, circulating bone turnover markers (BTM), and serum 25(OH)D were measured using commercially available kits. 24-hour urine and fecal calcium samples were analyzed at Litholink Corporation. Intestinal microbiota were chacterized by 16S rRNA Illumina paired-end sequencing, and QIIME and metaGenomeSeq software were used to analyze microbial community differences.
RESULTS: At one week, both male and female CTX animals showed a reversible, 3-fold increase in urinary calcium excretion coupled with a 25% increase in intestinal calcium absorption. These changes resulted in two-fold increase in calcium oxalate and phosphate urinary supersaturation. No differences were observed in serum labs, BTM, PTH, or vitamin D among the three groups. CTX microbial communities were markedly different from UTX and NEO groups by heat-map and discriminant plotting (Figure a/b) .
CONCLUSIONS: In our model, one week of chloramphenicol caused increased intestinal gut calcium absorption and resultant urinary calcium excretion without changes in circulating measures of bone and mineral homeostasis. Gut microbiome was markedly different between the three groups. Should these findings be validated in future studies, functional study of the gut microbial communities responsible for these changes may allow us to target and treat the gut microbiota responsible for absorptive hypercalciuria.
Source of Funding: NIH T32-DK094789

MP03-09 THE EFFECT OF AN ESCHERICHIA COLI BACTERIAL URINARY INFECTION ISOLATE AND CIPROFLOXACIN ON CALCIUM UROLITHIASIS IN A DROSOPHILA MELANOGASTER MODEL
Jennifer Bjazevic*, Kaitlin F. Al, Jaswanth Gorla, Hassan Razvi, Jeremy P. Burton, London, Canada INTRODUCTION AND OBJECTIVES: Exposure to both urinary bacteria and antibiotics may impact the formation of calcium-based stone disease. Prior epidemiological studies have shown a strong association between the development of stone disease and a history of culture-proven urinary tract infections treated with antibiotics. We aimed to further evaluate the potential effect of a non-urease producing bacteria isolate from a urinary tract infection, and treatment with the antibiotic ciprofloxacin, on the formation of calcium oxalate stones utilizing a Drosophila melanogaster (DM) fly model. METHODS: DM flies were treated with a combination of a nonurease producing strain of Escherichia coli UTI89 and 0.1% sodium oxalate food for the duration of the 14-day assay (n[30 per group). Treatment with ciprofloxacin occurred on day 5-7 of the assay at a sub-minimum inhibitory concentration of 0.2 mg/mL. DM control groups without the addition of UTI89 or ciprofloxacin were included for comparison. Inoculation with UTI89 was confirmed by culturing pulverized flies on lysogeny broth agar plates on days 1-5. Stone burden was assessed with a survival curve analysis and measured pixel intensity of dissected Malpighian tubules under birefringent microscopy.
RESULTS: UTI89 was cultured at a minimum concentration of 3x10 3 colony forming units/fly for up to three days post exposure in treated flies. There was a trend towards decreased survival in oxalate food treated flies for days 15-35; however, UTI89 treatment did not affect fly survival. Preliminary results suggest that at day 7 exposure to UTI89 increased calcium oxalate crystal production in Malpighian tubules (p[0.001), and treatment with ciprofloxacin attenuated this effect (p[0.012, Figure 1 ). Similar trends were observed at day 14; however, these results did not reach statistical significance (Figure 1) . CONCLUSIONS: Our findings further suggest that exposure to both a non-urease producing E. coli and ciprofloxacin may impact calcium oxalate stone formation in a DM urolithiasis model. Further INTRODUCTION AND OBJECTIVES: There is growing evidence to support a role of urinary bacteria in the development of calcium stone disease; however, the mechanisms by which urinary bacteria may influence calcium stone formation remain to be elucidated. Both osteopontin (OPN) and zinc (Zn) have been shown to play a role in calcium oxalate (CaOx) urolithiasis and have also been demonstrated to be involved in bacterial pathogenesis. We aimed to examine the effect of non-urease producing bacteria isolated from a urinary tract infection, as well as both OPN and Zn, on the adherence of calcium oxalate crystals to renal epithelial cells.
METHODS: HEK293 and MDCK renal epithelial cells were grown to 90% confluence on culture plates. Cells were exposed to a non-urease producing strain of Escherichia coli (UTI89) for 20 minutes at 37C (10 3 CFU). The cells were then incubated with CaOx crystal suspension (0.5mg/mL) in artificial urine with or without the addition of OPN (0.1 mg/ml) or zinc chloride (500 mg/L), for 20 minutes at 37C. Unattached crystals were washed free with culture media. The adherence of calcium oxalate crystals was determined with birefringence microscopy and quantified by pixel intensity with MatLab.
RESULTS: Microscopy following treatment exposure revealed live cells in all treatment groups, and bacterial rods visible in groups treated with UTI89. In the MDCK cells, exposure to UTI89 significantly increased crystal adherence (p<0.001, FIgure 1 ). Exposure to OPN and Zn were noted to have opposite effects in UTI89 treated cells, resulting in attenuated and enhanced crystal adherence respectively (p<0.001, Figure 1 ). Similar trends were observed in the HEK293 cells; however, these results did not reach statistical significance.
CONCLUSIONS: These findings suggest that non-urease producing E. coli impacts CaOx crystal adherence, and both Zn and OPN may have a novel role in this process. While Zn and OPN have previously been shown to be involved in both CaOx urolithiasis and bacterial pathogenesis; further investigation is required in order to delineate the potential mechanisms by which urinary pathogens alter crystal adherence, and the precise role that both Zn and OPN may play in this process. Calcium oxalate stone (60%-90%) is the most common type of nephrolithiasis, while the etiology is still unclear. Emerging evidence has linked the gut microbiome to nephrolithiasis. Some studies found that Oxalobacter formigenes, a member of the human gut microbiome, can degrade oxalate and obtain energy from it, which may decrease the level of oxalate in serum and urine. However, several prospective researches indicated that patients with calcium oxalate stones showed no significant change in urinary oxalate after oral administration of O. formigenes. Thus, the objectives of the study were to continually explore the gut microbiome and their metabolite which may play a major role in the formation of calcium oxalate stones.
Source of
METHODS: We performed microbiome analysis using 16S ribosomal RNA (rRNA) amplicon sequencing on fecal samples from 160 Chinese individuals, including 23 with recurrent renal calcium oxalate stones (RS), 53 with single stones (SS) and 84 non-stones (NS) people.
